News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
726,254 Results
Type
Article (41135)
Company Profile (264)
Press Release (684841)
Multimedia
Podcasts (85)
Webinars (20)
Section
Business (204750)
Career Advice (2027)
Deals (35553)
Drug Delivery (121)
Drug Development (81447)
Employer Resources (173)
FDA (16466)
Job Trends (14964)
News (346610)
Policy (32746)
Tag
2027 BioCapital Elite (1)
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2584)
Accelerated approval (42)
Adcomms (25)
Allergies (160)
Alliances (49577)
ALS (192)
Alzheimer's disease (1739)
Antibody-drug conjugate (ADC) (366)
Approvals (16783)
Artificial intelligence (593)
Autoimmune disease (222)
Automation (50)
Bankruptcy (362)
Best Places to Work (11636)
BIOSECURE Act (20)
Biosimilars (201)
Biotechnology (174)
Bladder cancer (177)
Brain cancer (63)
Breast cancer (685)
Cancer (5300)
Cardiovascular disease (442)
Career advice (1716)
Career pathing (39)
CAR-T (299)
CDC (53)
Celiac Disease (2)
Cell therapy (796)
Cervical cancer (41)
Clinical research (70215)
Collaboration (1884)
Company closure (4)
Compensation (1270)
Complete response letters (69)
COVID-19 (2724)
CRISPR (98)
C-suite (973)
Cystic fibrosis (148)
Data (7038)
Decentralized trials (3)
Denatured (26)
Depression (152)
Dermatology (57)
Diabetes (549)
Diagnostics (6823)
Digital health (52)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (292)
Drug pricing (194)
Drug shortages (29)
Duchenne muscular dystrophy (265)
Earnings (91055)
Editorial (60)
Employer branding (21)
Employer resources (152)
Events (118333)
Executive appointments (1030)
FDA (19878)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (29)
Funding (1609)
Gene editing (210)
Generative AI (51)
Gene therapy (651)
GLP-1 (1014)
Government (4692)
Grass and pollen (6)
Guidances (396)
Healthcare (18919)
HIV (73)
Huntington's disease (52)
IgA nephropathy (91)
Immunology and inflammation (271)
Immuno-oncology (80)
Indications (157)
Infectious disease (3036)
Inflammatory bowel disease (200)
Inflation Reduction Act (14)
Influenza (128)
Intellectual property (273)
Interviews (316)
IPO (16651)
IRA (50)
Job creations (3645)
Job search strategy (1429)
JPM (58)
Kidney cancer (18)
Labor market (92)
Layoffs (553)
Leadership (34)
Legal (7951)
Liver cancer (98)
Longevity (28)
Lung cancer (712)
Lymphoma (406)
Machine learning (52)
Management (59)
Manufacturing (917)
MASH (176)
Medical device (13849)
Medtech (13926)
Mergers & acquisitions (20059)
Metabolic disorders (1406)
mRNA (173)
Multiple sclerosis (172)
NASH (17)
Neurodegenerative disease (380)
Neuropsychiatric disorders (97)
Neuroscience (3124)
Neurotech (1)
NextGen: Class of 2026 (6522)
Non-profit (4525)
Now hiring (73)
Obesity (661)
Opinion (274)
Ovarian cancer (185)
Pain (227)
Pancreatic cancer (253)
Parkinson's disease (336)
Partnered (33)
Patents (552)
Patient recruitment (587)
Peanut (60)
People (59226)
Pharmaceutical (59)
Pharmacy benefit managers (32)
Phase 1 (21886)
Phase 2 (30915)
Phase 3 (23024)
Pipeline (7093)
Policy (302)
Postmarket research (2564)
Preclinical (9277)
Press Release (64)
Prostate cancer (274)
Psychedelics (49)
Radiopharmaceuticals (302)
Rare diseases (988)
Real estate (5958)
Recruiting (70)
Regulatory (24956)
Reports (54)
Research institute (2404)
Resumes & cover letters (353)
Rett syndrome (32)
RNA editing (17)
RSV (85)
Schizophrenia (163)
Series A (266)
Series B (200)
Service/supplier (11)
Sickle cell disease (106)
Special edition (22)
Spinal muscular atrophy (164)
Sponsored (45)
Startups (3624)
State (2)
Stomach cancer (18)
Supply chain (117)
Tariffs (85)
The Weekly (57)
Vaccines (1054)
Venture capital (98)
Weight loss (420)
Women's health (109)
Worklife (19)
Date
Today (58)
Last 7 days (637)
Last 30 days (2666)
Last 365 days (29925)
2026 (7978)
2025 (30171)
2024 (35212)
2023 (40075)
2022 (51175)
2021 (55710)
2020 (54085)
2019 (46538)
2018 (35019)
2017 (32108)
2016 (31483)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27329)
Location
Africa (738)
Alabama (90)
Alaska (7)
Arizona (331)
Arkansas (13)
Asia (39452)
Australia (6450)
California (12244)
Canada (3506)
China (1224)
Colorado (522)
Connecticut (520)
Delaware (366)
Europe (85207)
Florida (1847)
Georgia (393)
Hawaii (3)
Idaho (62)
Illinois (954)
India (80)
Indiana (558)
Iowa (22)
Japan (485)
Kansas (129)
Kentucky (44)
Louisiana (38)
Maine (73)
Maryland (1481)
Massachusetts (8749)
Michigan (346)
Minnesota (674)
Mississippi (6)
Missouri (138)
Montana (33)
Nebraska (29)
Nevada (135)
New Hampshire (82)
New Jersey (3267)
New Mexico (28)
New York (3231)
North Carolina (1553)
North Dakota (8)
Northern California (6054)
Ohio (365)
Oklahoma (22)
Oregon (41)
Pennsylvania (2481)
Puerto Rico (26)
Rhode Island (50)
South America (1111)
South Carolina (76)
South Dakota (1)
Southern California (4812)
Tennessee (199)
Texas (1923)
United States (43374)
Utah (367)
Vermont (1)
Virginia (291)
Washington D.C. (80)
Washington State (980)
West Virginia (4)
Wisconsin (118)
Wyoming (2)
726,254 Results for "medpace inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Medpace Holdings, Inc. to Report First Quarter 2026 Financial Results on April 22, 2026
March 25, 2026
·
1 min read
Press Releases
Medpace Holdings, Inc. Reports Fourth Quarter and Full Year 2025 Results
February 10, 2026
·
18 min read
Press Releases
Medpace Holdings, Inc. Reports Third Quarter 2025 Results
October 22, 2025
·
18 min read
Press Releases
Zelluna selects Medpace as CRO for ZIMA-101 first-in-human clinical trial
February 11, 2026
·
3 min read
Press Releases
Medpace Holdings, Inc. to Report Second Quarter 2025 Financial Results on July 21, 2025
June 24, 2025
·
1 min read
Press Releases
Medpace Holdings, Inc. Reports First Quarter 2025 Results
April 22, 2025
·
17 min read
Business
Medpace Holdings, Inc. to Report Second Quarter 2024 Financial Results on July 22, 2024
Medpace Holdings, Inc. announced that it will report its second quarter 2024 financial results after the market close on Monday, July 22, 2024.
June 26, 2024
·
1 min read
Press Releases
Medpace Holdings, Inc. to Report First Quarter 2025 Financial Results on April 21, 2025
March 19, 2025
·
1 min read
Business
Medpace Holdings, Inc. to Report First Quarter 2024 Financial Results on April 22, 2024
Medpace Holdings, Inc. announced that it will report its first quarter 2024 financial results after the market close on Monday, April 22, 2024.
March 28, 2024
·
1 min read
Business
Medpace Holdings, Inc. Reports First Quarter 2024 Results
Medpace Holdings, Inc. announced financial results for the first quarter ended March 31, 2024. First Quarter 2024 Financial Results Revenue for the three months ended March 31, 2024 increased 17.7% to $511.0 million, compared to $434.1 million for the comparable prior-year period.
April 22, 2024
·
17 min read
1 of 72,626
Next
